BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Kerecis Release: Minister of Industry Inaugurates Fish Skin Medical Device Facility


9/27/2011 8:34:08 AM

REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND--(Marketwire - September 26, 2011) -

Iceland's Minister of Industry Katrin Juliusdottir today inaugurated the Kerecis Medical Device manufacturing facility in Isafjordur, Iceland. The only one of its kind in Iceland, the GMP-compliant facility fulfills the requirements of FDA and European authorities.

Kerecis develops, manufactures and markets medical devices under the brand names MariGen™ and MariCell™. Both products contain collagen and Omega3 oils derived from fish skin, and are used to treat damaged skin and tissue.

The MariCell dermatology creams will be the initial products manufactured in the facility. This product line consists of three cream variants for the treatment of dry and cracked feet, red and inflamed skin, and dry and scaly skin. Sales of the products will start in Iceland in October and in overseas markets in the immediate future through distribution and private label agreements.

Comments from the inauguration ceremony:
G. Fertram Sigurjonsson, Kerecis Co-Founder and Chairman of the Board:
"The unique Kerecis technology requires specialized manufacturing equipment. In the new facility we will be producing products that address unmet clinical needs such as care for chronic wounds, which result in more than 100,000 amputations annually in the U.S. alone. In developing the technology used in this facility, we were fortunate to receive grants from technology development programs here in Iceland such as from the Ministry of Fisheries and Agriculture and from the Ministry of Industry's Technical Development fund."

Katrín Juliusdottir, Iceland's Minister of Industry:
"Kerecis has accomplished much in the past years, showing us how a traditional industry like the seafood industry can be a good platform for innovative businesses. I am certain that the choice of Isafjordur as a site for their facility will be good for the Kerecis stakeholders and the local community. With the facility, several new jobs will be created for both unskilled and skilled labor, which is good and exiting news for us all."

About Kerecis
Kerecis (http://www.kerecis.com) is a development and manufacturing business producing a novel, patent-pending tissue-regeneration material derived from fish skin to accelerate the healing of wounds and tissue reconstruction. The Kerecis material addresses the large unmet need of the double-digit-growth biologics segment of the chronic-wounds, hernia-repair and dermatology markets. The material offers advantages over existing human- and porcine-derived products, including improved manufacturing economics and lower risk of disease transfer. Since it is derived from fish, the material is both kosher and halal compatible, eliminating cultural and religious constraints on usage, with equivalent or better clinical performance. For more information, e-mail info@kerecis.com or call 703-879-6535 (U.S.) or 354-8494960 (Iceland).


For further information, contact:
G. Fertram Sigurjonsson
Chairman, Kerecis Limited
Phone (Iceland) +354 8494960 / (U.S.) (703) 879-6535
E-mail: Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

Kerecis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES